三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
HSK7653在国内在研DPP-4超长效抑制剂的研究数据中表现优异
HSK7653在国内在研DPP-4超长效抑制剂的研究数据中表现优异
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:288KB
图片尺寸:2327*1632
同报告图片
/
4
5aW955qE77yM5Lul5LiL5piv5LuO5Zu+54mH5Lit5o+Q5Y+W55qE5pWw5o2u5bm255Sf5oiQ55qE6KGo5qC877yaCgp8IOiNr+WTgeWQjeensCB8IOeglOWPkeacuuaehCB8IOWFqOeQg+mYtuautSB8IOS4reWbvemYtuautSB8IOeglOeptuaVsOaNriB8CnwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwKfCBIU0s3NjUzIHwg5rW35oCd56eRIHwg6I635om55LiK5biCIHwg6I635om55LiK5biCIHwg5q+PMuWRqDHmrKHvvIwxMOOAgTI144CBNTBtZ+Wkmuasoee7meiNr+WQju+8jDE0ZOWQjuWQhOWJgumHj+e7hOaKkeWItueOh+Wdh+e7tOaMgeWcqDgwJeS7peS4iuOAgiB8Cnwg5LyY5qC85YiX5rGAIHwg6IuR5Lic55Sf54mpIHwgSUlJ5pyf5Li05bqKIHwgSUlJ5pyf5Li05bqKIHwg5q+P5ZGoMeasoe+8jOe7meiNr+WQjjflpKlEUFAtNOaKkeWItueOh+Wdh+WcqDgwJeS7peS4iuOAguS4juWfuue6v+ebuOavlO+8jOS8mOagvOWIl+axgOeJhzIwMG1n44CBMzAwbWflkow0MDBtZ+WJgumHj+e7hEhiQTFj5YC85YiG5Yir5LiL6ZmNMC43OCXjgIEwLjUyJeWPijEuMDYl77yM56m66IW56KGA57OW5YC85YiG5Yir5LiL6ZmNMS4wNm1tb2wvTOOAgTEuNTltbW9sL0zlj4oxLjMwbW1vbC9M77yM6aSQ5ZCOMmjooYDns5blgLzliIbliKvkuIvpmY0yLjAxbW1vbC9M44CBMS4wN21tb2wvTOWPijIuMjdtbW9sL0zjgIIgfAp8IOWNmuagvOWIl+axgCB8IOWNjuS4nOeQhuW3peWkp+Wtpjsg55m+5p6B5Zyw6ZW/OyDkuIrmtbfoja/niannoJTnqbbmiYAgfCBJL0lJ5pyf5Li05bqKIHwgSS9JSeacn+S4tOW6iiB8IOavj+WRqDHmrKEgfAp8IOWlpeagvOWIl+axgCB8IE1lcmNrICYgQ28uIHwg5om55YeG5LiK5biCIHwg55Sz5oql5Li05bqKIHwg5q+P5ZGoMeasoe+8jOWFt+acieS4juavj+aXpeS4gOasoTUwbWfliYLph48o5pel5pys55qE5qCH5YeG6LW35aeL5YmC6YePKURQUC005oqR5Yi25YmC6KW/5qC85YiX5rGAKEphbnV2aWEp5ZCM562J55qE55aX5pWI5ZKM6ICQ5Y+X5oCn44CCIHwKfCDmm7LmoLzliJfmsYAgfCDnp5HkvKboja/kuJogfCDmibnlh4bkuIrluILvvIjljp/noJTvvJrmrabnlLDvvIkgfCDmibnlh4bkuIrluILvvIjpppbku7/vvIkgfCDmr4/lkagx5qyh77yM5L2/55SoMTAwbWfmm7LmoLzliJfmsYA35aSp5ZCO77yMRFBQLTTmtLvmgKfnmoTlubPlnYfmipHliLbnjofkuLo3Ny40JSzlronmhbDliYLnu4TkuLoyLjQlO+e7j+i/hzI05ZGo55qE6L+e57ut57uZ6I2v77yM57uT5p6c5pi+56S657OW5YyW6KGA57qi6JuL55m95rWT5bqmKEhiQTFjKeWSjOepuuiFueihgOezlua1k+W6puabsuagvOWIl+axgOe7hOWSjOmYv+agvOWIl+axgOe7hOWdh+aYvuekuuWHuumdnuW4uOaViOaAp+OAgiB8CgrotYTmlpnmnaXmupDvvJrljLvoja/prZTmlrnjgIHlvIDmupDor4HliLjnoJTnqbbmiYA=
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
所属报告:
海思科-公司首次覆盖报告:研发管线持续推进创新转型成效显著-241225(39页).pdf
打包全文图表
相关数据
JAK抑制剂在骨髓纤维化治疗中的竞争格局
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
收藏
竞争格局
2026-06-26
原图定位
查看详情
《KAT6抑制剂化合物、药物组合物及其制备方法和N-(6-((1H-pyrazol-1-yl)methyl)-4-metho
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
收藏
行业数据
2026-05-11
原图定位
查看详情
图10、全球PD-(L)1抑制剂市场规模(十亿美元)
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
收藏
市场规模
2026-05-11
原图定位
查看详情
2023年国内DPP-4i类降糖药企业份额
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
收藏
行业数据
2026-04-24
原图定位
查看详情
2019-2023年国内DPP-4i类降糖药市场规模(亿元)
fCDlubTku70gfCDluILlnLrop4TmqKHvvIjkur/lhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyMDE5IHwgMjkuNTAgICAgICAgICAgICB8CnwgMjAyMCB8IDQwLjgwICAgICAgICAgICAgfAp8IDIwMjEgfCA0OC43MiAgICAgICAgICAgIHwKfCAyMDIyIHwgNTAuMzggICAgICAgICAgICB8CnwgMjAyMyB8IDU1LjMzICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5pGp54a15ZKo6K+i77yM5Lic5YyX6K+B5Yi4
收藏
行业数据
2026-04-24
原图定位
查看详情
图10.VMAT2抑制剂全球销售情况(亿美元)
收藏
行业数据
2026-04-20
原图定位
查看详情
全球PCSK9抑制剂市场规模(亿美元)
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
收藏
市场规模
2026-04-13
原图定位
查看详情
中国PCSK9抑制剂市场规模(亿人民币)
收藏
市场规模
2026-04-13
原图定位
查看详情
数字产品护照(DPP)数据
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
收藏
行业数据
2026-04-02
原图定位
查看详情
相较于PD-(L)1抑制剂,PD-(L)1/VEGF双抗有极大替代和拓展空间
收藏
行业数据
2026-03-31
原图定位
查看详情
全球在研FXI/FXIa抑制剂的临床进展
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
收藏
行业数据
2026-02-26
原图定位
查看详情
FXI/FXIa抑制剂全球可触及患者数
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
收藏
行业数据
2026-02-26
原图定位
查看详情
图表11FDA获批KRASG12C抑制剂的全球销售额(百万美元)
收藏
行业数据
2026-02-25
原图定位
查看详情
图表19KRASG12D抑制剂竞争格局
收藏
竞争格局
2026-02-25
原图定位
查看详情
图3 mCRC中EGFR抑制剂的美国收入(2004-2017)
收藏
行业数据
2026-02-13
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
HSK7653于 2024年 6月获批,产品用于改善成人 2型糖尿病患者的血糖控制。HSK7653 是唯一的两周一次口服制剂,目前除维格列汀需每日口服 2 次外,其余国内已上市新药均需每日口服 1次,而科伦药业的曲格列汀仿制药每周口服 1次即可,是国内首款上市的 DPP-4 长效周制剂,该药的原研方是日本武田制药。苑东生物的优格列汀(Ⅲ期)、百极地长制药的博格列汀(Ⅰ期)、默沙东的奥格列汀(国外上市,国内获批临床)等药物也均为周制剂。HSK7653 作为 DPP-4超长效抑制剂,有望占据糖尿病药物的部分市场份额。
行业数据
原图定位
当前图表所属:
海思科-公司首次覆盖报告:研发管线持续推进创新转型成效显著-241225(39页).pdf
全球全身麻醉在研药物较少,且处在临床阶段
环泊酚市场竞争格局较优,剂型方面更具便利性
环泊酚六项适应症已被国家药监局获批
核心研发团队规模较大,硕博比例较高
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》